Возраст домена | 16 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | 10 |
Страниц в Google | 5560 |
Страниц в Яндексе | 403 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 1798160 |
Alexa Country | 176192 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Breaking World Pharma News
pharma, news, pharma news, pharmanews, world, pharmaceutical, industry, research, FDA, EMA, pharmacy, drugs, drug, clinical research, CRO, business, discovery, development, commercialisation, medicines, global
World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements
UTF-8
55.12 КБ
1 100
8 628 симв.
7 336 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
pharmaceutical-technology.com | 17 | 6 |
20 | 242818 | 101296 | |
thepharmatimes.in | 7 | 4 |
0 | 1274973 | 152284 | |
drugdevelopment-technology.com | 5 | 4 |
10 | 520087 | 226084 | |
jazzpharma.com | 5 | 6 |
0 | 633226 | 192566 | |
pharmainfocus.com.au | 5 | 4 |
0 | 1615703 | 31993 | |
pharma-mkting.com | 4 | 4 |
0 | 1817181 | 453817 | |
cleanroom.net | 4 | 4 |
0 | 14941306 | Нет данных | |
worldpharmaceuticals.net | 4 | 4 |
0 | 3590291 | Нет данных | |
fiercepharma.com | 4 | 6 |
0 | 106975 | 20815 | |
leo-pharma.com | 3 | 6 |
10 | 721738 | 24495 | |
libertarianprepper.com | 3 | 2 |
0 | 2296589 | 1482596 | |
pharmabiz.com | 2 | 5 |
20 | 421586 | 51691 | |
newsnow.co.uk | 2 | 6 |
0 | 2942 | 208 | |
medicalnewstoday.com | 2 | 6 |
0 | 1606 | 481 | |
in-pharmatechnologist.com | 2 | 6 |
20 | 486342 | 203379 | |
intoday.in | 2 | 7 |
0 | 990 | 78 | |
ft.com | 2 | 8 |
0 | 2126 | 1786 | |
forbes.com | 2 | 8 |
0 | 289 | 109 | |
drugs.com | 2 | 7 |
0 | 3848 | 1398 | |
biospace.com | 2 | 7 |
0 | 70695 | 19400 | |
Еще 30 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 15 Ноября 2016 ) | |
Количество ссылок на сайт | 1796 |
Количество доменов, которые ссылаются на сайт | 197 |
Количество найденных анкоров | 188 |
Исходящие (внешние) ссылки домена | 3522 |
Количество доменов, на которые ссылается сайт | 298 |
Количество исходящих анкоров | 346 |
Внешние ссылки главной страницы ( 10 ) | |
worldpharmajobs.com | WORLD PHARMA JOBS |
facebook.com/worldpharmanews nofollow | |
twitter.com/worldpharmanews nofollow | |
linkedin.com/groups/40567 nofollow | |
google.com/+Worldpharmanews nofollow | Google+ |
xing.com/communities/groups/world-pharma-news-d946-1067200 nofollow | |
feedproxy.google.com/worldpharmanews nofollow | RSS |
pharmanews.eu | PharmaNews.eu |
ehealthnews.eu | eHealthNews.eu |
healthitspace.eu | (HEALTH IT) SPACE |
Внутренние ссылки главной страницы ( 40 ) | |
worldpharmanews.com | World Pharma News |
/business-and-industry | Industry |
/research-and-development | Research |
/events | Events |
/regulatory | Regulatory |
/research | Research |
/research/5043-the-gut-may-be-involved-in-the-development-of... | The gut may be involved in the development of multiple sclerosis |
/research/5042-olaparib-becomes-first-gene-targeted-medicine... | Olaparib becomes first gene-targeted medicine to show benefits in prostate cancer |
/astrazeneca | AstraZeneca |
/astrazeneca/5041-astrazeneca-divests-rights-to-seroquel-and... | AstraZeneca divests rights to Seroquel and Seroquel XR in the US and Canada |
/pfizer | Pfizer |
/pfizer/5040-fda-approves-pfizer-s-biosimilar-abrilada-adali... | FDA approves Pfizer's biosimilar, ABRILADA™ (adalimumab-afzb) for multiple inflammatory conditions |
/research/5039-investigational-drugs-reduce-risk-of-death-fr... | Investigational drugs reduce risk of death from Ebola virus disease |
/astrazeneca/5038-imfinzi-granted-fda-priority-review-for-th... | Imfinzi granted FDA Priority Review for the treatment of patients with extensive-stage small cell lung cancer |
/bayer | Bayer |
/bayer/5037-bayer-selects-pharmaron-as-partner-organization | Bayer selects Pharmaron as partner organization |
/research/5036-pharmacist-led-interventions-may-help-prevent... | Pharmacist-led interventions may help prevent cardiovascular disease |
/roche | Roche |
/roche/5035-fda-grants-priority-review-to-roche-s-risdiplam-... | FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy |
/research/5034-a-protein-tag-to-study-the-immune-system | A protein tag to study the immune system |
/events/5033-excellent-market-conditions-at-largest-ever-cph... | Excellent market conditions at largest ever CPhI Worldwide bodes well for global pharma in 2020 |
/events/5032-smi-group-s-12th-annual-conference-and-exhibiti... | SMi Group's 12th Annual Conference and Exhibition: Pre-Filled Syringes and Injectable Drug Devices 2020 |
/fda/5031-fda-approves-novel-treatment-to-target-abnormality... | FDA approves novel treatment to target abnormality in sickle cell disease |
/research/5030-industry-executives-profits-drive-rising-pric... | Industry executives: Profits drive rising prices for MS drugs |
/events/5029-smi-s-4th-annual-3d-cell-culture | SMi's 4th Annual 3D Cell Culture |
/amgen/5028-amgen-completes-acquisition-of-otezla-apremilast | Amgen completes acquisition of Otezla® (apremilast) |
/bms/5027-bristol-myers-squibb-completes-acquisition-of-celg... | Bristol-Myers Squibb completes acquisition of Celgene, creating a leading biopharma company |
/fda/5026-fda-approves-first-treatment-for-inherited-rare-di... | FDA approves first treatment for inherited rare disease |
/research/5025-artificial-intelligence-algorithm-can-learn-t... | Artificial Intelligence algorithm can learn the laws of quantum mechanics and speed up drug delivery |
/research/5024-new-advances-in-the-treatment-of-advanced-lun... | New advances in the treatment of advanced lung cancer |
/events/5013-exploring-the-dynamics-legalities-and-hurdles-i... | Exploring the dynamics, legalities and hurdles in a period of transition for Parallel Trade |
/events/5009-rna-therapeutics-conference-and-focus-day | RNA Therapeutics Conference and Focus Day |
/events/5007-cphi-worldwide-announces-the-winners-of-the-16t... | CPhI Worldwide announces the winners of the 16th Pharma Awards |
/events/5003-cphi-annual-report-predicts-europe-to-surpass-t... | CPhI Annual Report predicts Europe to surpass the USA in biologic manufacturing capacity by 2023 |
/fda/5020-fda-approves-first-targeted-therapy-to-treat-patie... | FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease |
/fda/5010-fda-approves-first-therapy-to-treat-patients-with-... | FDA approves first therapy to treat patients with rare blood disorder |
/fda/4995-digital-submission-of-adverse-event-reports-for-in... | Digital submission of adverse event reports for investigational new drug applications |
/advertise#submit | Submit Your News! |
/terms-and-conditions#section1 | Terms of Use |
/contact | Contact |
Domain Name: WORLDPHARMANEWS.COM
Registry Domain ID: 1177745274_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.udag.net
Registrar URL: http://www.united-domains.de
Updated Date: 2018-10-02T07:16:42Z
Creation Date: 2007-08-24T16:00:23Z
Registry Expiry Date: 2019-08-24T16:00:23Z
Registrar: United-Domains AG
Registrar IANA ID: 1408
Registrar Abuse Contact Email: abuse@united-domains.de
Registrar Abuse Contact Phone: +49.8151368670
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS.UDAG.DE
Name Server: NS.UDAG.NET
Name Server: NS.UDAG.ORG
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-11-29T02:01:43Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
# If the Joomla site is installed within a folder such as at
# e.g. www.example.com/joomla/ the robots.txt file MUST be
# moved to the site root at e.g. www.example.com/robots.txt
# AND the joomla folder name MUST be prefixed to the disallowed
# path, e.g. the Disallow rule for the /administrator/ folder
# MUST be changed to read Disallow: /joomla/administrator/
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/orig.html
#
# For syntax checking, see:
# http://tool.motoricerca.info/robots-checker.phtml
User-agent: *
Disallow: /administrator/
Disallow: /bin/
Disallow: /cache/
Disallow: /cli/
Disallow: /components/
Disallow: /includes/
Disallow: /installation/
Disallow: /language/
Disallow: /layouts/
Disallow: /libraries/
Disallow: /logs/
Disallow: /modules/
Disallow: /plugins/
Disallow: /tmp/
США - Атланта - 74.63.178.17
ViaWest Internet Services
ViaWest
HTTP/1.1 200 OK
Server: nginx
Date: Thu, 05 Dec 2019 08:21:15 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
X-Powered-By: PHP/7.2.15
Expires: Wed, 17 Aug 2005 00:00:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Set-Cookie: d4dad6935f632ac35975e3001dc7bbe8=m6ut2j1jmu5enj146hn0alc5lm; path=/; HttpOnly
Last-Modified: Thu, 05 Dec 2019 08:21:15 GMT
X-Powered-By: PleskLin
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"